OX40 costimulation turns off Foxp3+ tregs

被引:319
作者
Vu, Minh Diem
Xiao, Xiang
Gao, Wenda
Degauque, Nicolas
Chen, Ming
Kroemer, Alexander
Killeen, Nigel
Ishii, Naoto
Li, Xian Chang
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Transplant Res Ctr, Boston, MA 02215 USA
[2] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[3] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 980, Japan
关键词
D O I
10.1182/blood-2007-01-070748
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OX40 is a recently identified T-cell costimulatory molecule that belongs to the TNF/TNFR superfamily. OX40 can be expressed by both activated T effector cells and Foxp3(+) Tregs. It is well known that OX40 delivers a potent costimulatory signal to T effector cells, but very little is known about the role of OX40 in regulating the suppressor properties of Foxp3(+) Tregs and the de novo generation of new inducible Foxp3(+) Tregs from T effector cells. In the present study, we found, by using a newly created foxp3gfp knockin model, that OX40 was dispensable for the genesis and suppressor functions of naturally arising CD4(+)Foxp3(+) Tregs, but stimulating OX40 on the Foxp3(+) Tregs abrogated their ability to suppress T effector cell proliferation, IFN-gamma production, and T effector cell-mediated allograft rejection. OX40 costimulation did not significantly affect proliferation and survival of the naturally arising Foxp3(+) Tregs, but profoundly inhibited Foxp3 gene expression. Importantly, OX40 costimulation to T effector cells prevented the induction of new inducible Foxp3(+) Tregs from T effector cells. Our study identified OX40 as a key negative regulator of Foxp3(+) Tregs and may have important clinical implications in models of transplantation and autoimmunity.
引用
收藏
页码:2501 / 2510
页数:10
相关论文
共 48 条
[1]   Signaling through OX40 (CD134) breaks peripheral T-cell tolerance [J].
Bansal-Pakala, P ;
Jember, AGH ;
Croft, M .
NATURE MEDICINE, 2001, 7 (08) :907-912
[2]   Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period [J].
Bayer, AL ;
Yu, AX ;
Adeegbe, D ;
Malek, TR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :769-777
[3]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[4]   Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients [J].
Blazar, BR ;
Sharpe, AH ;
Chen, AI ;
Panoskaltsis-Mortari, A ;
Lees, C ;
Akiba, H ;
Yagita, H ;
Killeen, N ;
Taylor, PA .
BLOOD, 2003, 101 (09) :3741-3748
[5]  
Bluestone JA, 1997, J IMMUNOL, V158, P1989
[6]  
CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261
[7]   Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions [J].
Chen, AI ;
McAdam, AJ ;
Buhlmann, JE ;
Scott, S ;
Lupher, ML ;
Greenfield, EA ;
Baum, PR ;
Fanslow, WC ;
Calderhead, DM ;
Freeman, GJ ;
Sharpe, AH .
IMMUNITY, 1999, 11 (06) :689-698
[8]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[9]   CD28-independent induction of experimental autoimmune encephalomyelitis [J].
Chitnis, T ;
Najafian, N ;
Abdallah, KA ;
Dong, V ;
Yagita, H ;
Sayegh, MH ;
Khoury, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (05) :575-583
[10]   Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity? [J].
Croft, M .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (08) :609-620